Your session is about to expire
← Back to Search
Procedure
Pericardiotomy for Cardiovascular Disease (PRINCE Trial)
N/A
Recruiting
Led By Sigrid Sandner
Research Sponsored by Population Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* Requiring surgical intervention on the proximal aorta, cardiac valves, and/or coronary arteries
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up over the duration of the follow-up (mean follow-up of 5 years)
Awards & highlights
No Placebo-Only Group
Summary
"This trial is investigating the use of posterior pericardiotomy in patients without a history of atrial fibrillation or flutter who are having cardiac surgery on an international scale."
Who is the study for?
This trial is for adults over 18 who need heart surgery on the aorta, valves, or coronary arteries and can give informed consent. It's not for those with a history of atrial fibrillation or flutter.
What is being tested?
The PRINCE trial is testing if doing a left posterior pericardiotomy during cardiac surgery can prevent complications like atrial fibrillation. Patients are randomly chosen to either get this procedure or not.
What are the potential side effects?
Potential side effects may include discomfort at the incision site, bleeding, infection risk from the additional surgical step, and possible impacts on heart function.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I need surgery on my heart or the main blood vessel coming from it.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ over the duration of the follow-up (mean follow-up of 5 years)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~over the duration of the follow-up (mean follow-up of 5 years)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Hierarchical composite of all-cause death, ischemic stroke, systemic arterial embolism, unplanned hospital visit/readmission for cardiac reasons, and atrial fibrillation.
In-hospital post-operative atrial fibrillation
Secondary study objectives
Death
Hospital readmission or unplanned hospital visit
Ischemic stroke or systemic arterial embolism
+4 moreOther study objectives
Number of patients requiring re-operation for bleeding
Number of patients with cardiac tamponade
Number of patients with esophageal injuries
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Left Posterior Pericardiotomy GroupExperimental Treatment1 Intervention
The surgeon will perform a left posterior pericardiotomy during the patient's cardiac surgery.
Group II: No Posterior Pericardiotomy GroupActive Control1 Intervention
The surgeon will not perform a posterior pericardiotomy during the patient's cardiac surgery.
Find a Location
Who is running the clinical trial?
McMaster UniversityOTHER
917 Previous Clinical Trials
2,613,965 Total Patients Enrolled
11 Trials studying Atrial Fibrillation
10,505 Patients Enrolled for Atrial Fibrillation
Population Health Research InstituteLead Sponsor
164 Previous Clinical Trials
717,114 Total Patients Enrolled
33 Trials studying Atrial Fibrillation
53,724 Patients Enrolled for Atrial Fibrillation
Hamilton Health Sciences CorporationOTHER
377 Previous Clinical Trials
339,000 Total Patients Enrolled
12 Trials studying Atrial Fibrillation
12,757 Patients Enrolled for Atrial Fibrillation
Share this study with friends
Copy Link
Messenger